MarkAWeissMD

Oncology • Philadelphia, PA

Professor, Medical Oncology, Jefferson Medical College-Thos Jefferson Univ

Join to view full profile

Dr. Weiss is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Weiss' full profile

Already have an account?

Office
925 Chestnut St
Suite 320a
Philadelphia, PA 19107
Phone+1 215-955-8874

Fax+1 215-955-2340
Is this information wrong?

Education & Training

Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1987 - 1990
Vanderbilt University Medical CenterResidency, Internal Medicine, 1983 - 1987
Weill Cornell MedicineClass of 1983

Certifications & Licensure

PA State Medical License 2009 - 2024
NY State Medical License 1987 - 2010
TN State Medical License 1985 - 1995
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2011-2013

Clinical Trials

Combination Chemotherapy and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia Start of enrollment: 1994 Jun 01
Completed
Phase 2
Pentostatin, Cyclophosphamide, and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Other B-cell Cancers Start of enrollment: 1998 Sep 01
Completed
Phase 2
Fludarabine, Cyclophosphamide, and Rituximab in Treating Patients Who Have Chronic Lymphocytic Leukemia Start of enrollment: 1998 Sep 01
Completed
Phase 2
Monoclonal Antibody in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Start of enrollment: 2002 Oct 01
Completed
Phase 1
Study of VELCADE® With Mitoxantrone and Etoposide for Leukemias Start of enrollment: 2006 Jan 01
Completed
Phase 1, Phase 2
Safety and Efficacy Study of Immunotherapy With Rituximab and Interleukin-2 in Patients With Non-Hodgkin's Lymphoma Start of enrollment: 2009 Feb 05
Completed
Phase 2
A Study of Bone Marrow Transplantation Using Fully-Matched Relatives as Donors for Patients With Hematological Malignancies Start of enrollment: 2008 Apr 10
Completed
Phase 2
A Research Study of Bone Marrow Transplantation From Unrelated or Partially Matched Related Donors Start of enrollment: 2011 Feb 10
Completed
Phase 2
Combination of Pentostatin, Bendamustine and Ofatumumab for Treatment of Chronic Lymphocytic Leukemia and Lymphoma Start of enrollment: 2011 May 25
Terminated
Phase 1
A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies Start of enrollment: 2011 Aug 04
Completed
Phase 2
Phase I/II Study of Bendamustine in Combination With Ofatumumab, Carboplatin and Etoposide Start of enrollment: 2011 Nov 09
Completed
Phase 1, Phase 2
Donor Stem Cell Boost in Treating Patients With Low Blood Cells After Donor Stem Cell Transplant Start of enrollment: 2012 Aug 01
Withdrawn
Not Applicable
Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies Start of enrollment: 2012 Dec 24
Completed
Phase 2
Sirolimus, Idarubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Start of enrollment: 2013 Mar 15
Completed
Early Phase 1
Sirolimus and Azacitidine in Treating Patients With High Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia That is Recurrent or Not Eligible for Intensive Chemotherapy Start of enrollment: 2013 Jul 08
Active, not recruiting
Phase 2
Haploidentical Donor Hematopoietic Stem Cell Transplant in Treating Patients With Hematologic Malignancies Start of enrollment: 2013 May 17
Terminated
Phase 2
Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia Start of enrollment: 2013 Dec 09
Active, not recruiting
Phase 3
Allogeneic Hematopoietic Stem Cell Transplantation for High-Risk Hematologic Malignancies Using One Haploidentical Donor Start of enrollment: 2013 Nov 04
Completed
Phase 2
Bendamustine Hydrochloride, Bortezomib, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma Start of enrollment: 2014 Aug 25
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

12 citations
Acquired uniparental disomy in chromosome 6p as a feature of relapse after T-cell replete haploidentical hematopoietic stem cell transplantation using cyclophosphamide...
Dolores Grosso, Erica S. Johnson, Beth W. Colombe, Onder Alpdogan, Matthew Carabasi, Joanne Filicko-O'Hara, Sameh Gaballa, Margaret Kasner, Thomas R. Klumpp, Ubaldo E....> ;Bone Marrow Transplantation. 2017 Jan 9
57 citations
Clostridium difficile colonization and disease in patients undergoing hematopoietic stem cell transplantation
Jackrapong Bruminhent, Zi-Xuan Wang, Carol Hu, John L. Wagner, Richard Sunday, Brent Bobik, Sarah E. Hegarty, Scott W. Keith, Seyfettin Onder Alpdogan, Matthew Carabas...> ;Biology of Blood and Marrow Transplantation. 2014 Sep 1
Liposomal vincristine for relapsed or refractory Ph-negative acute lymphoblastic leukemia: a review of literature.
Pathak, P.,Hess, R.,Weiss, M. A.> ;Ther Adv Hematol. 2014 Feb 04
Posttreatment interleukin-2 in patients with acute myeloid leukemia: The end of a long road for patients and clinical trials?
Grosso, D.,Weiss, M. A.> ;Cancer. 2014 Jan 03
Association of health-related quality of life with gender in patients with B-cell chronic lymphocytic leukemia.
Pashos, C. L.,Flowers, C. R.,Kay, N. E.,Weiss, M.,Lamanna, N.,Farber, C.,Lerner, S.,Sharman, J.,Grinblatt, D.,Flinn, I. W.,Kozloff, M.,Swern, A. S.,Street, T. K.,Sulli...> ;Support Care Cancer. 2013 Oct
Treatment of Adults with Acute Lymphoblastic Leukemia: Do the Specifics of the Regimen Matter?: Results from a Prospective Randomized Trial
Matt Kalaycio, Gary Schiller, Nicole Lamanna, Peter Maslak, Steven Coutre, Leonard T Heffner, Mark A Weiss> ;Wiley. 2013 Mar 15
Treatment of adult ALL: more questions than answers.
Kasner, M. T., Weiss, M.> ;Oncology (Williston Park, NY). 2012 Sep
Cognitive difficulties among patients with cancer receiving chemotherapy affects quality of life: A University of Rochester Clinical Community Oncology Program study o...
Janelsins MC, Devine K, Mustian KM, Mohile SG, Peppone LJ, Sprod L, Weiss M, Vinciguerra V, Jacobs A, Morrow GR> ;J. Clin. Oncol.. 2011-05-20
Survival outcomes in elderly patients with plasma cell myeloma: The three-decade Eastern Cooperative Oncology Group (ECOG) experience.
Campagnaro EL, Jacobus SJ, Uno H, Oken MM, Kyle RA, Rajkumar SV, Greipp PR, Vesole DH, Weiss M, Fonseca R, Lazarus HM> ;J. Clin. Oncol.. 2011-05-20
Prospective and observational study of pain and analgesic prescribing in medical oncology outpatients with breast, colorectal, lung, or prostate cancer.
Fisch M, Lee J, Weiss M, Wagner LI, Chang VT, Cella D, Manola J, Minasian LM, McCaskill-Stevens WJ, Mendoza TR, Cleeland CS> ;J. Clin. Oncol.. 2011-05-20
A phase III randomized prospective trial of the effect of psychotherapy on distress in 287 prostate cancer patients: A URCC CCOP Study.
Palesh O, Mustian K, Heckler C, Purnell J, Peppone L, Weiss M, Atkins JN, Dakhil SR, Spiegel D, Morrow G> ;J. Clin. Oncol.. 2009-05-20
Sequential Therapy with Fludarabine, High-Dose Cyclophosphamide, and Rituximab in Previously Untreated Patients with Chronic Lymphocytic Leukemia Produces High-Quality...
David A Scheinberg, Mark L Heaney, Ariela Noy, Andrew D Zelenetz, Mark A Weiss, Joseph G Jurcic, Peter Maslak, Nicole Lamanna, Renier J Brentjens> ;Journal of Clinical Oncology. 2008 Dec 17
A phase I trial for the treatment of purine analog-refractory chronic lymphocytic leukemia using autologous T cells genetically targeted to the B cell specific antigen...
Brentjens RJ, Hollyman D, Weiss M, Stefanski J, Przybylowski M, Bartido S, Borquez-Ojeda O, Taylor C, Heaney M, Riviere I, Sadelain M> ;J. Clin. Oncol.. 2008-05-20
Symptomatic response to a non-platinum doublet in performance status 2 (PS 2) patients (pts) with non-small lung cancer (NSCLC).
Spiridonidis H, Tao M, Laufman L, Laufman H, Weiss M, Ganz P> ;J. Clin. Oncol.. 2004-07-15
Combination therapy with voriconazole and caspofungin for fungal infections in patients with acute leukemia.
Lamanna N, Weiss MA> ;J. Clin. Oncol.. 2004-07-15
81 citations
Pentostatin and Cyclophosphamide: An Effective New Regimen in Previously Treated Patients With Chronic Lymphocytic Leukemia
Mark Weiss, Peter Maslak, Joseph G. Jurcic, David A. Scheinberg, Timothy Aliff, Nicole Lamanna, Stanley R. Frankel, Steven E. Kossman, Denise Horgan> ;Journal of Clinical Oncology. 2003 Apr 1
175 citations
Refractory Aspergillus pneumonia in patients with acute leukemia: successful therapy with combination caspofungin and liposomal amphotericin.
Timothy B. Aliff, Peter G. Maslak, Joseph G. Jurcic, Mark L. Heaney, Kathleen N. Cathcart, Kent A. Sepkowitz, Mark A. Weiss> ;Cancer. 2003 Feb 15
23 citations
A single, high dose of idarubicin combined with cytarabine as induction therapy for adult patients with recurrent or refractory acute lymphoblastic leukemia.
Mark A. Weiss, Timothy B. Aliff, Martin S. Tallman, Stanley R. Frankel, Matt E. Kalaycio, Peter G. Maslak, Joseph G. Jurcic, David A. Scheinberg, E B S Todd Roma> ;Cancer. 2002 Aug 1
26 citations
Acute myelogenous leukemia after exposure to strontium-89 for the treatment of adenocarcinoma of the prostate
Steven E. Kossman, Mark A. Weiss> ;Cancer. 2000 Feb 1
44 citations
Two cases of extramedullary acute promyelocytic leukemia. Cytogenetics, molecular biology, and phenotypic and clinical studies
Mark A. Weiss, Raymond P. Warrell> ;Cancer. 1994 Oct 1
Ultrastructure of the human mammary ductule.
Tannenbaum M, Weiss M, Marx AJ> ;Cancer. 1969-04-01
Join now to see all

Hospital Affiliations

Thomas Jefferson University HospitalPhiladelphia, Pennsylvania
Lankenau Medical CenterWynnewood, Pennsylvania
Fayetteville Veterans Affairs Medical CenterFayetteville, North Carolina

MarkAWeissMD

Dr. Weiss is on Doximity

Education & Training

Certifications & Licensure

Awards, Honors, & Recognition

Clinical Trials

Publications & Presentations

Hospital Affiliations

Viewing the full profile is available to verified healthcare professionals only.